LNCaP  Xenografts

 

 

Rincon Bio performs LNCaP xenograft models to test efficacy of preclinical therapies.  Please see below for additional information or to request a quote. 

Prostate

DU-LNCaP cells were derived from 50 year old male Caucasian with carcinoma

Notes

Genes expressed: human prostatic acid phosphatase; prostate specific antigen

Receptor Expression: androgen receptor, positive; estrogen receptor, positive

in vivo

Used in xenografts to test the efficacy of novel cancer therapeutics.  Tumors develop after being injected into the flank of immunocompromised mice. 

Request Quote

Receive a quote within one business day for a LNCaP Xenograft

Rincon Bio Growth Curve

lncap.png

Cell Line: LNCaP

Mouse Strain: Nod-Scid Gamma from Jackson, Male

Animals per Group: 5

Positive Control: None

Concentration: N/A

Matrigel: Yes

Dosing schedule: N/A

Cells Implanted per Animal: 5.5 million

Stratified: N/A

Stratification size: N/A

Days from implant to stratification: N/A

WHY WORK WITH

RINCON BIO?

DOMESTIC QUALITY at COMPETITIVE PRICES

 

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

SPEED TO INITIATION
 

Most efficacy studies can be initiated within two business days.

PERSONAL TOUCH

 

We love our clients!  We are flexible and easy to work with.  And we take a personal interest in our clients' studies.